Clinical Results with a B Cell Activating Anti-CD73 Antibody for the Immunotherapy of COVID-19
View ORCID ProfileRichard A. Miller, Pramod Guru, Philippe Bauer, Jorge Robles, Christian Tomaszewski, J. Scott Overcash, Michael Waters, Miriam Cameron, Julián Olalla Sierra, James Janc, Jenny A. Rudnick, Shenshen Hu, William B. Jones, Long Kwei, Suresh Mahabhashyam, Stephen B. Willingham, Gerard Criner
doi: https://doi.org/10.1101/2021.09.13.21263406
Richard A. Miller
1Corvus Pharmaceuticals, Burlingame, CA, USA
Pramod Guru
2Mayo Clinic, Jacksonville, FL, USA
Philippe Bauer
3Mayo Clinic, Rochester, MN, USA
Jorge Robles
4El Centro Regional Medical Center, El Centro, CA, USA
Christian Tomaszewski
4El Centro Regional Medical Center, El Centro, CA, USA
5University of California, San Diego, CA, USA
J. Scott Overcash
6Sharp Grossmont Hospital, La Mesa, CA, USA
Michael Waters
7Sharp Chula Vista Medical Center, Chula Vista, CA, USA
Miriam Cameron
8Holy Cross Hospital, Silver Spring, MD, USA
Julián Olalla Sierra
9Hospital Costa del Sol, Marbella, Spain
James Janc
1Corvus Pharmaceuticals, Burlingame, CA, USA
Jenny A. Rudnick
1Corvus Pharmaceuticals, Burlingame, CA, USA
Shenshen Hu
1Corvus Pharmaceuticals, Burlingame, CA, USA
William B. Jones
1Corvus Pharmaceuticals, Burlingame, CA, USA
Long Kwei
1Corvus Pharmaceuticals, Burlingame, CA, USA
Suresh Mahabhashyam
1Corvus Pharmaceuticals, Burlingame, CA, USA
Stephen B. Willingham
1Corvus Pharmaceuticals, Burlingame, CA, USA
Gerard Criner
10Temple University Hospital, Philadelphia, PA, USA

Article usage
Posted September 21, 2021.
Clinical Results with a B Cell Activating Anti-CD73 Antibody for the Immunotherapy of COVID-19
Richard A. Miller, Pramod Guru, Philippe Bauer, Jorge Robles, Christian Tomaszewski, J. Scott Overcash, Michael Waters, Miriam Cameron, Julián Olalla Sierra, James Janc, Jenny A. Rudnick, Shenshen Hu, William B. Jones, Long Kwei, Suresh Mahabhashyam, Stephen B. Willingham, Gerard Criner
medRxiv 2021.09.13.21263406; doi: https://doi.org/10.1101/2021.09.13.21263406
Clinical Results with a B Cell Activating Anti-CD73 Antibody for the Immunotherapy of COVID-19
Richard A. Miller, Pramod Guru, Philippe Bauer, Jorge Robles, Christian Tomaszewski, J. Scott Overcash, Michael Waters, Miriam Cameron, Julián Olalla Sierra, James Janc, Jenny A. Rudnick, Shenshen Hu, William B. Jones, Long Kwei, Suresh Mahabhashyam, Stephen B. Willingham, Gerard Criner
medRxiv 2021.09.13.21263406; doi: https://doi.org/10.1101/2021.09.13.21263406
Subject Area
Subject Areas
- Addiction Medicine (216)
- Allergy and Immunology (495)
- Anesthesia (106)
- Cardiovascular Medicine (1101)
- Dermatology (141)
- Emergency Medicine (274)
- Epidemiology (9782)
- Gastroenterology (481)
- Genetic and Genomic Medicine (2318)
- Geriatric Medicine (223)
- Health Economics (463)
- Health Informatics (1563)
- Health Policy (737)
- Hematology (238)
- HIV/AIDS (507)
- Medical Education (240)
- Medical Ethics (67)
- Nephrology (258)
- Neurology (2148)
- Nursing (134)
- Nutrition (338)
- Oncology (1183)
- Ophthalmology (366)
- Orthopedics (129)
- Otolaryngology (220)
- Pain Medicine (148)
- Palliative Medicine (50)
- Pathology (313)
- Pediatrics (698)
- Primary Care Research (267)
- Public and Global Health (4673)
- Radiology and Imaging (781)
- Respiratory Medicine (624)
- Rheumatology (274)
- Sports Medicine (210)
- Surgery (252)
- Toxicology (43)
- Transplantation (120)
- Urology (94)